Total Payments
$280,127
2024 Payments
$20,402
Companies
17
Transactions
279
Medicare Patients
824
Medicare Billing
$129,899
Payment Breakdown by Category
Other$223,849 (79.9%)
Travel$29,935 (10.7%)
Consulting$12,996 (4.6%)
Research$7,226 (2.6%)
Food & Beverage$6,121 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $189,849 | 64 | 67.8% |
| Travel and Lodging | $29,935 | 95 | 10.7% |
| Grant | $25,000 | 1 | 8.9% |
| Consulting Fee | $12,996 | 3 | 4.6% |
| Honoraria | $9,000 | 1 | 3.2% |
| Unspecified | $7,226 | 2 | 2.6% |
| Food and Beverage | $6,121 | 113 | 2.2% |
Payments by Type
General
$272,901
277 transactions
Research
$7,226
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $133,911 | 121 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $79,514 | 103 | $0 (2018) |
| Medtronic Vascular, Inc. | $25,237 | 3 | $0 (2017) |
| ABIOMED | $17,809 | 20 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $13,947 | 11 | $0 (2018) |
| Abbott Laboratories | $5,050 | 3 | $0 (2018) |
| Medicure Pharma Inc. | $2,226 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $1,194 | 2 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $248.30 | 2 | $0 (2018) |
| Boston Scientific Corporation | $210.01 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,402 | 14 | Janssen Pharmaceuticals, Inc ($10,495) |
| 2023 | $21,252 | 17 | Janssen Pharmaceuticals, Inc ($17,622) |
| 2022 | $19,395 | 16 | Janssen Pharmaceuticals, Inc ($15,204) |
| 2021 | $10,413 | 7 | Janssen Pharmaceuticals, Inc ($10,413) |
| 2020 | $9,911 | 8 | Janssen Pharmaceuticals, Inc ($9,911) |
| 2019 | $23,903 | 26 | Janssen Pharmaceuticals, Inc ($23,546) |
| 2018 | $55,006 | 71 | Otsuka America Pharmaceutical, Inc. ($32,946) |
| 2017 | $119,845 | 120 | Otsuka America Pharmaceutical, Inc. ($46,569) |
All Payment Transactions
279 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $10.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $54.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $3.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $9.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $740.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/31/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $62.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/30/2024 | ABIOMED | Impella (Device) | Honoraria | Cash or cash equivalent | $9,000.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/30/2024 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $765.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/21/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $113.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/30/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,410.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $51.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,040.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/01/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $15.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/21/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,270.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/18/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,270.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/13/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $46.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/12/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/15/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,270.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/10/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/04/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/29/2023 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $1,412.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/27/2023 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $66.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2023 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $529.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2023 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $1,366.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Evaluation of the Thrombogenic Potential of Company's Implant | Abbott Laboratories | $5,000 | 1 |
| Shear Stress Platelet Activation | Medicure Pharma Inc. | $2,226 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 218 | 393 | $92,370 | $40,735 |
| 2022 | 4 | 237 | 383 | $82,887 | $38,215 |
| 2021 | 4 | 199 | 330 | $66,534 | $30,791 |
| 2020 | 4 | 170 | 280 | $50,987 | $20,158 |
Total Patients
824
Total Services
1,386
Medicare Billing
$129,899
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 155 | 329 | $72,943 | $33,393 | 45.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 49 | 49 | $17,885 | $6,399 | 35.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 14 | 15 | $1,542 | $943.24 | 61.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 121 | 242 | $54,067 | $25,346 | 46.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 49 | 49 | $17,885 | $6,211 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 49 | $6,566 | $3,393 | 51.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 29 | 43 | $4,369 | $3,265 | 74.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 98 | 190 | $42,224 | $20,586 | 48.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 101 | $13,651 | $6,247 | 45.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 27 | 27 | $9,855 | $3,320 | 33.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 12 | $804.00 | $637.54 | 79.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 85 | 163 | $22,076 | $9,365 | 42.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 39 | 69 | $15,249 | $5,822 | 38.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 33 | 33 | $12,162 | $4,143 | 34.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 15 | $1,500 | $827.62 | 55.2% |
About Dr. Marvin Slepian, MD
Dr. Marvin Slepian, MD is a Cardiovascular Disease healthcare provider based in Tucson, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518039908.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marvin Slepian, MD has received a total of $280,127 in payments from pharmaceutical and medical device companies, with $20,402 received in 2024. These payments were reported across 279 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($189,849).
As a Medicare-enrolled provider, Slepian has provided services to 824 Medicare beneficiaries, totaling 1,386 services with total Medicare billing of $129,899. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Tucson, AZ
- Active Since 11/14/2006
- Last Updated 05/16/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1518039908
Products in Payments
- XARELTO (Drug) $133,911
- SAMSCA (Drug) $79,514
- HeartWare HVAD (Device) $25,137
- Impella (Device) $17,809
- PRALUENT ALIROCUMAB INJECTION (Biological) $14,195
- Xience V coronary stent system (Device) $5,027
- Aggrastat (tirofiban HCl) (Drug) $2,226
- BRILINTA (Drug) $1,075
- HD-IVUS (Device) $184.28
- Manta (Device) $152.86
- KENGREAL (Drug) $103.61
- SYNERGY (Device) $101.57
- CoreValve Evolut (Device) $100.17
- CARDIOFORM Septal Occluder (Device) $86.59
- MOSAIC (Device) $52.94
- WATCHMAN (Device) $36.15
- GENERAL STRUCTURAL HEART (Device) $36.14
- RHYTHMIA (Device) $29.13
- The SynCardia Total Artificial Heart (Device) $26.00
- Asahi Fielder coronary guide wire (Device) $23.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Tucson
Thomas Waggoner, D.o, D.O
Cardiovascular Disease — Payments: $543,824
Cardiovascular Disease $543,824
Paul Fenster, Md, MD
Cardiovascular Disease — Payments: $192,170
Cardiovascular Disease $192,170
Karl Kern, Md, MD
Cardiovascular Disease — Payments: $167,139
Cardiovascular Disease $167,139
Dr. Stephen Algeo, Md, MD
Cardiovascular Disease — Payments: $111,127
Cardiovascular Disease $111,127
Kartik Reddy, Md, MD
Cardiovascular Disease — Payments: $81,896
Cardiovascular Disease $81,896
Mark Goldberg, M.d, M.D
Cardiovascular Disease — Payments: $70,960
Cardiovascular Disease $70,960